Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Biomimetic nanovesicles can speed up diabetic wound healing by regulating immune cell behavior and metabolism.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Mesalazine may help treat extensive alopecia areata effectively.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Tofacitinib treatment is used for teenagers with alopecia areata.

RCS-01 is safe and may help rejuvenate aging skin.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.